Literature DB >> 23203151

Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer.

Yukiharu Todo1, Noriaki Sakuragi.   

Abstract

A consensus regarding the therapeutic role of lymphadenectomy in endometrial cancer has not been reached because of conflicting negative results of randomized controlled trials and positive results of a cohort study. Since the effects of new treatments tend to be overestimated in observational studies, positive results of an observational study should be validated by a future trial. However, special difficulties are presented in randomized controlled trials in surgery. External validity is important for guaranteeing the reliability of a result of the trial. Physicians' recruitment of eligible patients into a trial depends on the confidence of those physicians for a surgical procedure, workplace environment and feelings of personal responsibility relevant to patients' risk of recurrence. When two surgical procedures are compared in a randomized controlled trial, technical quality control may be reduced in the complicated surgery group due to experienced surgeons' non-participation. It is highly possible that the recruitment issue is a threat to external validity. Therefore, a randomized controlled trial may not be the best format for demonstrating the full benefits of complicated surgery. Multiple studies have demonstrated that the results of well-designed observational studies can be reliable and are comparable with those of randomized controlled trials. Journal editors and funding sources are requested to become more generous with observational studies, especially prospective cohort studies.

Entities:  

Mesh:

Year:  2012        PMID: 23203151     DOI: 10.1007/s10147-012-0499-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  45 in total

1.  Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; E Preti; F Landoni; S Carinelli; A Colombo; C Marini; C Sessa
Journal:  Ann Oncol       Date:  2011-09       Impact factor: 32.976

Review 2.  Complexity and contradiction in clinical trial research.

Authors:  R I Horwitz
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

3.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; N J Lembo; W S Weintraub; A S Kosinski; H X Barnhart; M H Kutner; N P Alazraki; R A Guyton; X Q Zhao
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

Review 4.  Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature.

Authors:  P M Ellis
Journal:  Ann Oncol       Date:  2000-08       Impact factor: 32.976

Review 5.  Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma.

Authors:  P J Allen; A Stojadinovic; C D Shriver; D P Jaques
Journal:  Ann Surg Oncol       Date:  1998 Jul-Aug       Impact factor: 5.344

6.  Randomized versus historical controls for clinical trials.

Authors:  H Sacks; T C Chalmers; H Smith
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

7.  Bias in treatment assignment in controlled clinical trials.

Authors:  T C Chalmers; P Celano; H S Sacks; H Smith
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

8.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

9.  Surgical and oncology trials for rectal cancer: who will participate?

Authors:  James D Harrison; Michael J Solomon; Jane M Young; Alan Meagher; George Hruby; Glenn Salkeld; Stephen Clarke
Journal:  Surgery       Date:  2007-07       Impact factor: 3.982

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  4 in total

Review 1.  The role of para-aortic lymphadenectomy in endometrial cancer.

Authors:  Mariam M AlHilli; Andrea Mariani
Journal:  Int J Clin Oncol       Date:  2013-02-15       Impact factor: 3.402

2.  FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.

Authors:  Satoko Sudo; Naoya Hattori; Osamu Manabe; Fumi Kato; Rie Mimura; Keiichi Magota; Hiroyuki Sugimori; Kenji Hirata; Noriaki Sakuragi; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-13       Impact factor: 9.236

Review 3.  Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

Authors:  Giorgio Bogani; Sean C Dowdy; William A Cliby; Fabio Ghezzi; Diego Rossetti; Andrea Mariani
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

4.  Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.

Authors:  Hiroyuki Yamazaki; Yukiharu Todo; Chisa Shimada; Sho Takeshita; Shinichiro Minobe; Kazuhira Okamoto; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2017-12-11       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.